Vaxart Inc ORD (VXRT)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO, CA 94080

Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using tablets that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Vaxart has believes that its proprietary tablet vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the company to develop oral versions of currently marketed vaccines and to design recombinant vaccines for new indications. Its development programs currently include tablet vaccines designed to protect against coronavirus, Norovirus, seasonal influenza and respiratory syncytial virus (RSV), as well as a therapeutic vaccine for human papillomavirus (HPV), Vaxart's first immuno-oncology indication. Vaxart has filed broad domestic and international patents covering its proprietary technology and creations for oral vaccination using adenovirus and TLR3 agonists.

Data as of 2021-06-13 09:27:07 -0400
Market Cap1.069 Billion Shares Outstanding122.268 Million Avg 30-day Volume10.799 Million
P/E Ratio-22.77064 Dividend Yield0.0 EPS-0.46
Price/Sales509.08 Debt to Equity1.17 EBITDA-42.774 Million
Price to Book Value4.77 Forward PE-9.22 Enterprise Value669.288 Million
Total Cash170.696 Million Current Debt11.642 Million Gross Profit1.65 Million
BETA0.35773 52-week High/Low24.9 / 2.26 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from VXRT instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 148 134 10.45% 31 (1.83%) 29 (1.68%) 6.9%
13F shares: 32.031 Million 35.468 Million -9.69% 4.211 Million 7.338 Million -42.61%
% Ownership 27.1984 32.4002 -16.05% 3.5758 6.7034 -46.66%
New Positions: 41 41 0.0% 11 9 22.22%
Increased Positions 46 46 0.0% 11 6 83.33%
Closed Positions 22 29 -24.14% 9 10 -10.0%
Reduced Positions 41 26 57.69% 7 8 -12.5%
Total Calls 2.996 Million 3.093 Million -3.14% 931.8 Thousand 683.1 Thousand 36.41%
Total Puts 2.251 Million 2.527 Million -10.95% 220.6 Thousand 450.4 Thousand -51.02%
PUT/CALL Ratio 0.75 0.82 -8.54% 0.24 0.66 -63.64%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding VXRT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VXRT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

259.4 Thousand total shares from 5 transactions

Exercise Derivative Conversion (M)

267.6 Thousand total shares from 7 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TUCKER SEAN SVP, CHIEF SCIENTIFIC OFFICER

  • Officer
100,000 2021-06-16 3

FINNEY MICHAEL J.

  • Director
15,097 2021-06-16 1

ECHERD MARGARET SVP, PRINCIPAL ACCNTNG OFFICER

  • Officer
100,000 2021-06-16 3

DAVIS TODD C

  • Director
15,097 2021-06-16 1

YEDID ROBERT A.

  • Director
15,097 2021-06-16 2

FLOROIU CEZAR ANDREI PRESIDENT, CHIEF EXEC OFFICER

  • Officer
  • Director
250,000 2021-06-16 1

WILSON KAREN J

  • Director
15,097 2021-06-16 3

WHEADON DAVID E.

  • Director
65,700 2021-06-16 2

LATOUR WOUTER

  • Director
1,500,000 2021-05-06 4

ARMISTICE CAPITAL, LLC

ARMISTICE CAPITAL MASTER FUND LTD.

BOYD STEVEN

  • Director
291,046 2020-06-26 1

MAHER ILLYA KEITH

  • Director
0 2019-10-25 0

RICHARD JOHN P

  • Director
20,000 2019-10-11 0

VANLENT ANNE

  • Director
0 2019-06-12 0

COX GEOFFREY F

  • Director
0 2019-06-12 0

MARKHAM RICHARD J

  • Director
0 2019-06-12 0

HARLAND JOHN M CHIEF FINANCIAL OFFICER

  • Officer
761 2018-09-11 0

CARE CAPITAL III LLC

CARE CAPITAL INVESTMENTS III L.P.

CARE CAPITAL OFFSHORE INVESTMENTS III LP

  • 10% Owner
30,793,670 2018-02-13 0

LESCHLY JAN

  • Director
  • 10% Owner
30,793,670 2018-02-13 0

LIFE SCIENCE ANGEL INVESTORS III, LLC

  • 10% Owner
0 2018-02-13 0

PLUMB RUSSELL H

  • Director
0 2017-05-18 0

DOUGHERTY MICHAEL R

  • Director
0 2017-05-18 0

DUNNE MICHAEL W.

  • Director
0 2017-05-18 0

ANIDO ARMANDO

  • Director
0 2017-05-18 0

PATTI JOSEPH M CEO

  • Officer
  • Director
0 2017-04-03 0

COLONNESE MARK P CHIEF FINANCIAL OFFICER

  • Officer
0 2017-04-03 0

FOX JAMES

  • Director
2,500 2015-08-11 0

AZZARELLO PETER CHIEF ACCOUNTING OFFICER

  • Officer
0 2015-08-11 0

HILL RICHARD JAMES

  • Director
7,500 2014-05-15 0

COOK PETER CHAPMAN

  • Director
0 2013-05-01 0

ERRINGTON JEFFERY

  • Director
0 2013-05-01 0

BELL PAUL RONALD

  • Director
6,248 2012-11-08 0

GUST IAN D.

  • Director
95,970 2012-11-08 0

KESSLER PAUL D. SVP CLINICAL, MED. & REG.; CMO

  • Officer
105,128 2012-04-05 0

DAVIS PETER B

  • Director
0 2011-05-25 0

CASTALDI DAVID L

  • Director
0 2011-05-25 0

HARVEY RICHARD A JR

  • Director
0 2011-05-25 0

LYNCH TIMOTHY P

  • Director
0 2011-05-25 0

ARYEH JASON

  • Director
0 2011-05-25 0

FAHIM RAAFAT E F PRESIDENT, CEO AND CFO

  • Officer
  • Director
373,474 2011-04-01 0

KALNIK MATTHEW W. SVP STRATEGIC PLAN. & BUS. OPS

  • Officer
71,050 2011-04-01 0

KNOTT DAVID M

  • 10% Owner
No longer subject to file 2009-06-29 0

JENCKES LINDA

  • Director
0 2009-05-22 0

SUDOVAR STEPHEN

  • Director
0 2009-05-22 0

HUDSON LESLIE

  • Director
0 2008-05-07 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

WHEADON DAVID E. - Director

2021-06-17 19:29:43 -0400 2021-06-16 A 65,700 a 65,700 direct

YEDID ROBERT A. - Director

2021-06-17 19:28:39 -0400 2021-06-16 A 15,097 a 15,097 direct

ECHERD MARGARET - Officer SVP, PRINCIPAL ACCNTNG OFFICER

2021-06-17 16:24:47 -0400 2021-06-16 A 100,000 a 100,000 direct

FINNEY MICHAEL J. - Director

2021-06-17 19:26:44 -0400 2021-06-16 A 15,097 a 15,097 direct

DAVIS TODD C - Director

2021-06-17 19:25:48 -0400 2021-06-16 A 15,097 a 15,097 direct

TUCKER SEAN - Officer SVP, CHIEF SCIENTIFIC OFFICER

2021-06-17 16:23:18 -0400 2021-06-16 A 100,000 a 100,000 direct

WILSON KAREN J - Director

2021-06-17 19:27:36 -0400 2021-06-16 A 15,097 a 15,097 direct

FLOROIU CEZAR ANDREI - Director - Officer PRESIDENT, CHIEF EXEC OFFICER

2021-06-17 16:22:12 -0400 2021-06-16 A 250,000 a 250,000 direct

YEDID ROBERT A. - Director

2021-06-14 16:17:37 -0400 2021-06-11 S 10,000 $8.61 d 8,240 direct -0.2561 0.0 1 -0.2561 2

ECHERD MARGARET - Officer SVP, PRINCIPAL ACCNTNG OFFICER

2021-06-14 16:16:09 -0400 2021-06-11 M 334 d 3,333 direct

ECHERD MARGARET - Officer SVP, PRINCIPAL ACCNTNG OFFICER

2021-06-14 16:16:09 -0400 2021-06-11 M 334 $5.17 a 334 direct -0.2561 0.0 1 -0.2561 2

YEDID ROBERT A. - Director

2021-06-14 16:17:37 -0400 2021-06-11 M 18,240 $0.31 a 18,240 direct -0.2561 0.0 1 -0.2561 2

ECHERD MARGARET - Officer SVP, PRINCIPAL ACCNTNG OFFICER

2021-06-14 16:16:09 -0400 2021-06-11 S 1,802 $8.00 d 0 direct yes -0.2561 0.0 1 -0.2561 2

YEDID ROBERT A. - Director

2021-06-14 16:17:37 -0400 2021-06-11 M 18,240 d 36,480 direct

ECHERD MARGARET - Officer SVP, PRINCIPAL ACCNTNG OFFICER

2021-06-14 16:16:09 -0400 2021-06-11 M 1,468 d 33,754 direct

ECHERD MARGARET - Officer SVP, PRINCIPAL ACCNTNG OFFICER

2021-06-14 16:16:09 -0400 2021-06-11 M 1,468 $0.77 a 1,802 direct -0.2561 0.0 1 -0.2561 2

ECHERD MARGARET - Officer SVP, PRINCIPAL ACCNTNG OFFICER

2021-06-11 16:17:58 -0400 2021-06-09 S 47,555 $8.00 d 0 direct yes -10.6407 0.0 1 -10.6407 2

ECHERD MARGARET - Officer SVP, PRINCIPAL ACCNTNG OFFICER

2021-06-11 16:17:58 -0400 2021-06-09 M 35,222 d 35,222 direct

ECHERD MARGARET - Officer SVP, PRINCIPAL ACCNTNG OFFICER

2021-06-11 16:17:58 -0400 2021-06-09 M 35,222 $0.77 a 47,555 direct -10.6407 0.0 1 -10.6407 2

ECHERD MARGARET - Officer SVP, PRINCIPAL ACCNTNG OFFICER

2021-06-11 16:17:58 -0400 2021-06-09 M 12,333 d 3,667 direct

ECHERD MARGARET - Officer SVP, PRINCIPAL ACCNTNG OFFICER

2021-06-11 16:17:58 -0400 2021-06-09 M 12,333 $5.17 a 12,333 direct -10.6407 0.0 1 -10.6407 2

LATOUR WOUTER - Director

2021-05-10 17:05:37 -0400 2021-05-07 M 100,000 d 700,000 direct

LATOUR WOUTER - Director

2021-05-10 17:05:37 -0400 2021-05-07 M 100,000 $1.70 a 100,000 direct -5.102 -0.8746 0.0 1 -8.1633 3

LATOUR WOUTER - Director

2021-05-10 17:05:37 -0400 2021-05-07 S 100,000 $7.13 d 0 direct -5.102 -0.8746 0.0 1 -8.1633 3

LATOUR WOUTER - Director

2021-05-10 17:05:37 -0400 2021-05-06 M 100,000 $1.70 a 100,000 direct -5.102 -0.8746 0.0 1 -8.1633 3

LATOUR WOUTER - Director

2021-05-10 17:05:37 -0400 2021-05-06 M 100,000 d 800,000 direct

LATOUR WOUTER - Director

2021-05-10 17:05:37 -0400 2021-05-06 S 100,000 $6.54 d 0 direct -5.102 -0.8746 0.0 1 -8.1633 3

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
VAXART INC VXRT 2021-06-17 22:15:03 UTC -6.1059 6.1459 550000
VAXART INC VXRT 2021-06-17 21:45:03 UTC -6.1036 6.1436 550000
VAXART INC VXRT 2021-06-17 21:15:03 UTC -6.1036 6.1436 550000
VAXART INC VXRT 2021-06-17 20:45:04 UTC -6.1232 6.1632 550000
VAXART INC VXRT 2021-06-17 20:15:03 UTC -6.1232 6.1632 550000
VAXART INC VXRT 2021-06-17 19:45:03 UTC -6.1232 6.1632 550000
VAXART INC VXRT 2021-06-17 19:15:03 UTC -6.1232 6.1632 550000
VAXART INC VXRT 2021-06-17 18:45:04 UTC -6.1716 6.2116 550000
VAXART INC VXRT 2021-06-17 18:15:03 UTC -6.1716 6.2116 550000
VAXART INC VXRT 2021-06-17 17:45:03 UTC -6.1716 6.2116 550000
VAXART INC VXRT 2021-06-17 17:15:03 UTC -6.1716 6.2116 550000
VAXART INC VXRT 2021-06-17 16:45:03 UTC -6.2065 6.2465 550000
VAXART INC VXRT 2021-06-17 16:15:02 UTC -6.2065 6.2465 550000
VAXART INC VXRT 2021-06-17 15:45:03 UTC -6.2065 6.2465 550000
VAXART INC VXRT 2021-06-17 15:15:03 UTC -6.2065 6.2465 550000
VAXART INC VXRT 2021-06-17 14:45:02 UTC -5.8074 5.8474 100000
VAXART INC VXRT 2021-06-17 14:15:03 UTC -5.8074 5.8474 100000
VAXART INC VXRT 2021-06-17 13:45:03 UTC -5.8074 5.8474 100000
VAXART INC VXRT 2021-06-17 13:15:03 UTC -5.8074 5.8474 85000
VAXART INC VXRT 2021-06-17 12:45:02 UTC -5.8074 5.8474 65000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund VXRT -23500.0 shares, $-142175.0 2021-03-31 N-PORT
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund VXRT -2562.0 shares, $-15500.1 2021-03-31 N-PORT
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund VXRT -15116.0 shares, $-162950.48 2021-04-30 N-PORT

Elevate your investments